InvestorsHub Logo
Post# of 304045
Next 10
Followers 3598
Posts 78318
Boards Moderated 1
Alias Born 03/25/2007

Re: None

Friday, 07/25/2014 2:30:40 PM

Friday, July 25, 2014 2:30:40 PM

Post# of 304045
MONEY RUNNERS NEW PLAY IS AMBS!

AMBS is our new MONSTER stock breakout play! Now at .16. Our price target is .20 PLUS! We believe the big gains will come next week with AMBS!

AMBS is going to be a nice and slow up gainer money runners....

Details about today's momentum play are at the bottom of this message.

Get ready to bank BIG on AMBS money runners group. The chart is set up perfectly here!

Huge awareness coming on AMBS! Recent news below explains everything!

Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations




NEW YORK and SAN FRANCISCO, Jul 23, 2014 (GLOBE NEWSWIRE via COMTEX) --

Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (otcqb:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, today announced a presentation by Dr. Thomas Arendt, Professor at University of Leipzig, at the 3rd Alzheimer's focused #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit, powered by MDM Worldwide on Thursday, July 31, 2014 at the United Nations in New York City, NY. Dr. Arendt will summarize his scientific hypotheses regarding the evolutional context of Alzheimer's disease, and an emerging therapeutic target in a 30 minute presentation in the afternoon session.

"I am pleased to accept the organizers' offer to present at #C4CT," said Dr. Arendt. "After being the first to identify the scientific principles underpinning Amarantus' diagnostic blood test LymPro, I have continued my research into Alzheimer's disease with a strong focus on human tissue evaluation from Alzheimer's patients. I believe there is a need to take a much broader perspective in thinking about Alzheimer's, and I am pleased to have this unique forum to share my perspective with the world."

Dr. Thomas Arendt is Professor of Neuroscience and runs the Paul Flechsig Institute of Brain Research which is a Research Institute of Leipzig University with about 50 staff members. He is also the Director of the Alzheimer Centre Leipzig and Director of the Interdisciplinary Centre for Clinical Research Leipzig. He has over 30 years of experience in R&D of therapeutic and diagnostic strategies of neurodegenerative disorders and has made several seminal contributions to therapeutic concepts of Alzheimer´s disease, including stem cell therapy and modulating tumor suppressor genes. He has published work in top-ranked journals, including Cell, Nature, J.Cell Biol., J. Neurosci., and holds several patents for CNS diagnostics and treatment with some of them out-licensed to biotech companies in the United States. Over the last 30 years, his research has continuously been funded by the German Research Foundation, German Federal Ministry for Education and Research, European Commission and others. In the early eighties of the 20th century, he was involved in identifying the degeneration of the cholinergic system in Alzheimer´s disease laying the basis for todays´ only available treatments. He is one of the pioneers of the "cell-cycle theory" of Alzheimer´s disease which he developed further towards a diagnostic and therapeutic concept.

The #C4CT Concussion Awareness Summit is being convened on July 31, 2014 to explore the potential link between TBI and Alzheimer's disease. A diverse working group of clinicians, medical researchers, policy makers, international diplomats, athletes, celebrities, and philanthropic organizations will be assembled to raise awareness, advance clinical research, and develop public policy in order to address this major unmet medical need and public health issue.

Our momentum play went up over 400% From our alert at .006 today! Congrats all those who made money! .006 to .026! Huge move on our "fun play".

Our team would like to get our members input on today's play. Let us know if you like momentum plays or not. As previously stated momentum plays are risky but also give a great chance to make quick money for our members!


MONEY RUNNERS GROUP

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.